跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUVEXX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUVEXX
Authorized
STANDARD
SUVEXX
ARALEZ PHARMACEUTICALS CANADA INC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
802e61e14bf3a0a7
Company
ARALEZ PHARMACEUTICALS CANADA INC
Type
Standard
Approval Details
Approval Id
802e61e14bf3a0a7
Drug Approval Canada Name
SUVEXX
Product Name
SUVEXX
Status
Marketed
Status Date
2020-07-24
Original Market Date
2020-07-24
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
28:08.04.04 , 28:32.28
Atc Original
N02CC51 SUMATRIPTAN AND NAPROXEN
Aig Number
0262035001
Company Name
ARALEZ PHARMACEUTICALS CANADA INC
Company Address
6733 Mississauga Rd, Suite 800 Mississauga Ontario Canada L5N 6J5
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
802e61e14bf3a0a7
Type
Standard
Back to Health Canada Approvals